Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2026 07:20 ET | Source: Dyadic International, Inc.

Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)

Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
March 02, 2026 07:20 ET | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone

Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milesto
February 17, 2026 07:25 ET | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin

Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin
December 17, 2025 07:20 ET | Source: Dyadic International, Inc.

Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets

Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutri
December 15, 2025 07:20 ET | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
December 01, 2025 07:25 ET | Source: Dyadic International, Inc.

Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets

Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
November 12, 2025 16:05 ET | Source: Dyadic International, Inc.

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress
November 10, 2025 07:25 ET | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
October 29, 2025 07:25 ET | Source: Dyadic International, Inc.

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
October 06, 2025 08:30 ET | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments

Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments